Patrik Tolf - Vitrolife Chief Officer

All Insiders . Sweden . 
Stock . Vitrolife AB . Stakeholders . Insider . Patrik Tolf
VITR Stock  SEK 228.60  7.20  3.25%   

Insider

Patrik Tolf is Chief Officer of Vitrolife AB
Age 53
Phone46 3 17 21 80 00
Webhttps://www.vitrolife.com

Vitrolife Management Efficiency

The company has return on total asset (ROA) of 0.0205 % which means that it generated a profit of $0.0205 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0246 %, meaning that it generated $0.0246 on every $100 dollars invested by stockholders. Vitrolife's management efficiency ratios could be used to measure how well Vitrolife manages its routine affairs as well as how well it operates its assets and liabilities.
Vitrolife AB has accumulated 2.03 B in total debt with debt to equity ratio (D/E) of 4.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vitrolife AB has a current ratio of 4.69, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Vitrolife until it has trouble settling it off, either with new capital or with free cash flow. So, Vitrolife's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vitrolife AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vitrolife to invest in growth at high rates of return. When we think about Vitrolife's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Hakon GrondalArion banki hf
35
Catarina ForsgrenAxfood AB
N/A
Mattias AnderssonKinnevik Investment AB
47
Svante HedinSkandinaviska Enskilda Banken
N/A
Sandra BranstadAxfood AB
48
Petra AlundSkandinaviska Enskilda Banken
56
Ainar LeppnenSkandinaviska Enskilda Banken
51
Bjrn WittmarkViva Wine Group
70
Christopher BischoffKinnevik Investment AB
50
Victor WangNordic Asia Investment
N/A
Masih YazdiSkandinaviska Enskilda Banken
43
Benedikt GislasonArion banki hf
49
Anna MollerViva Wine Group
N/A
Javiera RagnartzSkandinaviska Enskilda Banken
54
Pawel WyszynskiSkandinaviska Enskilda Banken
N/A
sa DomeijAxfood AB
61
Thomas NordenNordic Asia Investment
36
Olafur HoskuldssonArion banki hf
42
Gent JanssonSkandinaviska Enskilda Banken
N/A
Gustav KinnanderFormPipe Software AB
N/A
Alexander BergendorfAxfood AB
N/A
Vitrolife AB , a medical device company, develops, produces, and markets products for assisted reproduction. Vitrolife AB was founded in 1981 and is headquartered in Gothenburg, Sweden. Vitrolife operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 415 people. Vitrolife AB (VITR) is traded on Stockholm Exchange in Sweden and employs 1,073 people.

Management Performance

Return On Equity0.0246
Return On Asset0.0205

Vitrolife AB Leadership Team

Elected by the shareholders, the Vitrolife's board of directors comprises two types of representatives: Vitrolife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vitrolife. The board's role is to monitor Vitrolife's management team and ensure that shareholders' interests are well served. Vitrolife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vitrolife's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rickard Ericsson, Vice President Market Region EMEA & Americas
Daniel Forss, VP Consumables
Claus Bisgaard, VP Technologies
Ricardo Capella, VP Services
Karin Russberg, VP Sustainability
Patrik Tolf, Chief Officer
Thomas MSc, Pres CEO

Vitrolife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vitrolife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0246
Return On Asset0.0205
Profit Margin0.12 %
Operating Margin0.20 %
Current Valuation28.19 B
Shares Outstanding135.45 M
Shares Owned By Insiders32.02 %
Shares Owned By Institutions43.80 %
Price To Earning58.44 X
Price To Book1.61 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vitrolife Stock Analysis

When running Vitrolife's price analysis, check to measure Vitrolife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitrolife is operating at the current time. Most of Vitrolife's value examination focuses on studying past and present price action to predict the probability of Vitrolife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitrolife's price. Additionally, you may evaluate how the addition of Vitrolife to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY